WHO
FDA clears Sanofi TB drug indication
December 2, 2014Research and Development, Sales and Marketing Bedaquiline, FDA, Sanofi, WHO, priftin, rifapentine, sirturo
The FDA has approved Sanofi’s Priftin for a new tuberculosis (TB) indication following a priority review from the regulator. Priftin …
George Freeman: UK pharma is vital for our landscape
December 1, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, UK, WHO, freeman, medicine, stratified
The ABPI says the UK has an opportunity to benefit from stratified medicine, and the body’s 2014 conference held in …
GSK Ebola vaccine ‘promising’ in early trials
November 27, 2014Research and Development, Sales and Marketing Africa, Ebola, GSK, Takeda, Vaccine, WHO, vaccines
The first trial results for GlaxoSmithKline’s (GSK) Ebola vaccine candidate have shown that the medicine was well-tolerated and produced an …
UK lags behind in healthcare outcomes index
November 26, 2014Research and Development, Sales and Marketing Japan, NHS, UK, WHO, economist, health outcomes
Whilst healthcare outcomes in the UK arguably remain among the best in the world according to recent findings by The …
Takeda: we’re working on Ebola too
November 24, 2014Research and Development, Sales and Marketing Ebola, GSK, Gates, Obama, WHO, brett wells, pharmafile, rajeev, vaccines, venkaya, venkayya
The president of Takeda Vaccines has told Pharmafile that the Japanese firm has identified compounds that could help prevent infection …
Antibiotics: will the industry saviour please stand up
November 24, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Antibiotics, EAA, MRC, WHO, resistance, susie lunt
The spectre of a new ‘dark ages’ for humanity where common infections begin to kill again is increasingly making itself …
Antibiotic resistance ranking high among public concerns
November 18, 2014Research and Development, Sales and Marketing Antibiotics, Cameron, WHO, longitude, rees, terrorism
People in the UK believe antibiotic resistance is second only to terrorism among threats to the public, according to a …
EU and drug industry set aside €280m for Ebola
November 7, 2014Research and Development, Sales and Marketing Africa, Ebola, WHO, chan, vaccines, virus, west
The EU’s Innovative Medicines Initiative (IMI) has unveiled a new programme to find vaccines, drugs and diagnostics for Ebola, funded …
Chinese military-linked firm says it has Ebola cure
October 14, 2014Medical Communications, Sales and Marketing Ebola, WHO, amms, brincidofovir, sihuan pharmaceutical holdings, tekmira, zmapp
A Chinese drugmaker that has close military ties is seeking fast-track approval for its JK-05 drug that it says can …
NICE releases ‘person-centred’ medicines optimisation guidelines
October 14, 2014Research and Development, Sales and Marketing ABPI, NHS, NICE, UK, WHO, Whitehead
NICE has recently released the draft of its first guidance on medicines optimisation that it hopes will be more person-centered …
GSK Ebola vaccine fast-tracked into human trials
August 28, 2014Sales and Marketing Africa, Ebola, GSK, WHO, zmapp
GlaxoSmithKline has announced that its experimental Ebola vaccine is being fast-tracked into human studies to help deal with the worst-ever …
Untested Ebola drugs can be used in Africa
August 13, 2014Research and Development, Sales and Marketing Africa, Biocryst Pharmaceuticals, Ebola, Siga Technologies, Tekmira Pharmaceuticals, WHO, world health organization, zmapp
The World Health Organization will allow untested treatments for Ebola to be used in West Africa as the death toll …
GSK Ebola vaccine underway
August 11, 2014Research and Development, Sales and Marketing Africa, Ebola, GSK, Vaccine, WHO, johnson
Clinical trials of an experimental vaccine against the deadly Ebola virus will begin soon according to its developers GlaxoSmithKline. The …
US doctor infected with Ebola as disease spreads
July 28, 2014Medical Communications, Sales and Marketing Ebola, WHO
An American doctor working with Ebola patients in Liberia has been infected with the virus as health officials struggle to …
More action needed on antibiotic resistance
July 25, 2014Medical Communications, Research and Development, Sales and Marketing AMR, Antibiotics, AstraZeneca, GSK, HIV, MRC, WHO, walsh
Pharma and governments need to put their heads together urgently in order to tackle the threat of antimicrobial resistance (AMR), …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
